SEC Filing Summary: Neuralstem, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Neuralstem, Inc. on April 10, 2007. The report discloses corporate governance changes effective April 1, 2007. Note: The request metadata references "Palisade Bio, Inc.", but the filing text explicitly identifies the registrant as Neuralstem, Inc.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is limited to the appointment of a corporate officer.
Material Changes
The primary material change reported is the appointment of John Conron as Chief Financial Officer, effective April 1, 2007. Mr. Conron, age 56, is a Certified Public Accountant with over 30 years of experience in corporate finance, including previous CFO roles at Cyberstar, Inc. and Transworld Telecommunications, Inc.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. It confirms that Mr. Conron has not entered into any related person transactions with the Company.
Investor Verification Checklist
- Verify the effective date of John Conron's appointment as CFO (April 1, 2007).
- Review the attached press release (Exhibit 99.1) for additional details on the appointment.
- Confirm the registrant name is Neuralstem, Inc., not Palisade Bio, Inc.
- Note that no financial performance data is provided in this specific filing.